361 Capital’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$504K Sell
15,580
-4,000
-20% -$109K 0.24% 224
2020
Q1
$470K Buy
19,580
+70
+0.4% +$2.02K 0.21% 245
2019
Q4
$570K Sell
19,510
-1,550
-7% -$41.2K 0.16% 259
2019
Q3
$487K Sell
21,060
-850
-4% -$17.8K 0.09% 277
2019
Q2
$412K Sell
21,910
-3,220
-13% -$61.1K 0.07% 289
2019
Q1
$450K Buy
25,130
+3,290
+15% +$54.9K 0.08% 288
2018
Q4
$297K Sell
21,840
-2,210
-9% -$31.7K 0.06% 297
2018
Q3
$365K Sell
24,050
-420
-2% -$7.17K 0.08% 304
2018
Q2
$423K Sell
24,470
-34,920
-59% -$673K 0.1% 292
2018
Q1
$1.21M Buy
59,390
+310
+0.5% +$6.14K 0.3% 211
2017
Q4
$1.09M Sell
59,080
-93,770
-61% -$1.84M 0.27% 180
2017
Q3
$2.83M Sell
152,850
-153,210
-50% -$2.49M 0.54% 52
2017
Q2
$4.33M Buy
306,060
+109,380
+56% +$1.6M 0.73% 55
2017
Q1
$2.52M Buy
196,680
+80,710
+70% +$949K 0.54% 66
2016
Q4
$1.23M Buy
+115,970
New +$1.18M 0.29% 73

Other funds holding LRCX

361 Capital's LRCX Position: Q2 2020 in Review

361 Capital reduced its Lam Research (LRCX) stake by 20% in Q2 2020, selling an estimated $109K and leaving 15,580 shares worth $504K. The position accounts for 0.24% of the portfolio, ranked #224.

361 Capital first reported a position in LRCX in Q4 2016 and has held it in 15 quarters since. The position peaked at $4.33M in Q2 2017. 1,057 funds tracked by Wall St. Rank hold LRCX as of Q2 2020.

  • 361 Capital held 15,580 shares of Lam Research worth $504K as of Q2 2020.
  • 361 Capital sold 4,000 Lam Research shares in Q2 2020, an estimated $109K.
  • Lam Research made up 0.24% of 361 Capital's portfolio in Q2 2020, its #224 holding.
  • 361 Capital first reported a position in Lam Research in Q4 2016 and has held it in 15 quarters since.
  • 361 Capital's Lam Research position peaked at $4.33M in Q2 2017.
  • 1,057 funds tracked by Wall St. Rank held Lam Research as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.